Novartis confirms long term benefits of Gilenya in MS

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

Novartis confirms long term benefits of Gilenya in MS

Postby MSUK » Wed Sep 25, 2013 1:04 am

Novartis International AG has announced that new data showing the benefits of Gilenya on patient outcomes in multiple sclerosis will be presented at the 29th Congress of the European Committee for Research and Treatment in Multiple Sclerosis in Copenhagen, Denmark..... Read More - http://www.ms-uk.org/gilenya
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2159
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Gilenya

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service